Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

That 500 million shares last February was the result of hype from SRL, a company in India that was selling DR-70 kits they bought second-hand from Guar Diagno.

SRL sold their DR-70 kits at a 50% discount. They must have sold them all because SRL removed the DR-70 test kits from their website.

The SRL sales last year did not benefit Radient because Radient had already been paid for those kits. SRL did not order more test kits from Radient.

If you're expecting hype THIS February, where will it come from? UNI, perhaps? Unfortunately, sales by UNI won't benefit Radient -- Radient gets only $100,000 per year from UNI regardless of how many kits UNI manufactures and sells.